Cyclerion Therapeutics (CYCN) Gains from Investment Securities (2018 - 2025)
Cyclerion Therapeutics (CYCN) recorded quarterly Gains from Investment Securities of $297762.0 in Q4 2025, up 358.1% quarter-over-quarter from $65000.0 in Q2 2024.
Cyclerion Therapeutics (CYCN) Gains from Investment Securities (2018 - 2025) Analysis & Trends
Cyclerion Therapeutics' Gains from Investment Securities history runs 8 years deep, the most recent figure standing at $297762.0 for Q4 2025.
- In Q4 2025, Gains from Investment Securities changed N/A year-over-year to $297762.0; the TTM figure through Dec 2025 stood at $297762.0 (changed N/A YoY), while the FY2025 annual figure was $297762.0, down 11.23% from the prior year.
- Gains from Investment Securities was $297762.0 for Q4 2025 at Cyclerion Therapeutics, up from $65000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $5.4 million in Q4 2021 to a low of -$91000.0 in Q1 2023.
- Historically, Gains from Investment Securities has averaged $725614.7 across 5 years, with a median of $297762.0 in 2025.
- The sharpest annual moves came in 2021 and 2023: Gains from Investment Securities soared 652.76% in 2021, then slumped 120.22% in 2023.
- A 5-year view of Gains from Investment Securities shows it stood at $5.4 million in 2021, then tumbled by 94.94% to $274000.0 in 2022, then plunged by 133.21% to -$91000.0 in 2023, then soared by 171.43% to $65000.0 in 2024, then surged by 358.1% to $297762.0 in 2025.
- The last three Gains from Investment Securities figures came in at $297762.0 (Q4 2025), $65000.0 (Q2 2024), and -$91000.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Cyclerion Therapeutics | 11.94 Mn | 8.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 297,762.00 |
| Dec 31, 2025 | 297,762.00 |
| Jun 30, 2024 | 65,000.00 |
| Jun 30, 2024 | 65,000.00 |
| Mar 31, 2023 | -91,000.00 |
| Mar 31, 2023 | -91,000.00 |
| Dec 31, 2022 | 274,000.00 |
| Dec 31, 2022 | 274,000.00 |
| Sep 30, 2022 | 375,000.00 |
| Sep 30, 2022 | 375,000.00 |
| Jun 30, 2022 | 450,000.00 |
| Jun 30, 2022 | 450,000.00 |
| Mar 31, 2022 | 450,000.00 |
| Mar 31, 2022 | 450,000.00 |
| Dec 31, 2021 | 5.41 Mn |
| Dec 31, 2021 | 5.41 Mn |
| Sep 30, 2021 | 450,000.00 |
| Sep 30, 2021 | 450,000.00 |
| Jun 30, 2021 | 150,000.00 |
| Jun 30, 2021 | 150,000.00 |